• Feb 22, 2010 from 12:00pm to 1:00pm
  • Location: Online Webinar
  • Latest Activity: Aug 21, 2019
The year 2009 was rough for the capital markets, and while some believe that the worst is over, it has become clear that we must rethink the way that we finance new ventures. While many investors have moved away from very early stage investments in order to minimize risk, others argue that these times are indeed the best to start new companies. How can we best support these companies to minimize their risk? This webinar will discuss how non-dilutive funding can be utilized alongside private or venture investments and corporate partnerships as a source of capital for early stage ventures creating a new capital efficient model. Within this context, nanotechnology-based applications, in such areas as personalized medicine and clean technology, remain at the forefront of both government funding sources and venture capital. Only $30 for registration.
E-mail me when people leave their comments –

You need to be a member of The International NanoScience Community - Nanopaprika.eu to add comments!

Join The International NanoScience Community - Nanopaprika.eu